Journey with AxxessBio:
Stay informed with our latest news, press releases and shared milestones

AxxessBio and BioScenergy enter into an exclusive distributorship in Inborn errors of metabolism

June 2018, AxxessBio and BioScenergy entered into an exclusive distribution agreement for BioScenergy’s Valens Metabolics range of products in selected countries in Asia.


These products are for Inborn Errors of Metabolism (IEM) which are rare genetic disorders characterised by abnormal chemical reactions in the body disrupting the normal food metabolism.


BioScenergy is based in Kuala Lumpur, Malaysia. It specialises in medical nutrition, niche products and compounded medicines that are modular, halal certified and suited to Asian patients’ needs.


For more information on BioScenergy and its Valens Metabolics products, please visit


Interested in Partnering Up?

At AxxessBio, we are continuously looking for partnerships to bring new innovative therapies for patients all around Asia